Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38123684.
- Also identified by DOI 10.1038/s41586-023-06870-3 and PMC identifier 10765524.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Progression through the cell cycle is controlled by regulated and abrupt changes in phosphorylation<sup>1</sup>. Mitotic entry is initiated by increased phosphorylation of mitotic proteins, a process driven by kinases<sup>2</sup>, whereas mitotic exit is achieved by counteracting dephosphorylation, a process driven by phosphatases, especially PP2A:B55<sup>3</sup>. Although the role of kinases in mitotic entry is well established, recent data have shown that mitosis is only successfully initiated when the counterbalancing phosphatases are also inhibited<sup>4</sup>. Inhibition of PP2A:B55 is achieved by the intrinsically disordered proteins ARPP19<sup>5,6</sup> and FAM122A<sup>7</sup>. Despite their critical roles in mitosis, the mechanisms by which they achieve PP2A:B55 inhibition is unknown. Here, we report the single-particle cryo-electron microscopy structures of PP2A:B55 bound to phosphorylated ARPP19 and FAM122A. Consistent with our complementary NMR spectroscopy studies, both intrinsically disordered proteins bind PP2A:B55, but do so in highly distinct manners, leveraging multiple distinct binding sites on B55. Our extensive structural, biophysical and biochemical data explain how substrates and inhibitors are recruited to PP2A:B55 and provide a molecular roadmap for the development of therapeutic interventions for PP2A:B55-related diseases.
Medical subject headings
- Cryoelectron Microscopy
- Intracellular Signaling Peptides and Proteins
- Intrinsically Disordered Proteins
- Phosphoproteins
- Protein Phosphatase 2